Horizon Therapeutics Publ... (HZNP)
NASDAQ: HZNP
· Real-Time Price · USD
116.30
0.00 (0.00%)
At close: Jan 16, 2025, 10:00 PM
Horizon Therapeutics Public Revenue Breakdown
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actimmune Revenue | 29.04M | 29.12M | 30.22M | 34.44M | 29.99M | 31.43M | 30.56M | 30.06M | 27.78M | 28.76M | 35.68M | 28.31M | 28.3M | 26.54M | 28.42M | 27.86M | 29.28M | 21.75M | 27.49M | 25.83M | 27.38M | 24.86M | n/a | 61.6M | 36M |
| Actimmune Revenue Growth | -0.28% | -3.63% | -12.25% | +14.84% | -4.60% | +2.86% | +1.66% | +8.23% | -3.43% | -19.39% | +26.03% | +0.05% | +6.62% | -6.61% | +2.00% | -4.83% | +34.63% | -20.90% | +6.43% | -5.66% | +10.16% | n/a | -100.00% | +71.11% | n/a |
| B U P H E N Y L Revenue | 1.25M | 1.41M | 2.06M | 1.72M | 1.39M | 2.16M | 2.07M | 1.87M | 2.26M | 1.66M | 2.16M | 3.23M | 2.85M | 2.31M | 1.63M | 3.04M | 2.37M | 2.77M | 6.47M | 4.35M | 5.24M | 5.74M | n/a | 12.1M | 7.8M |
| B U P H E N Y L Revenue Growth | -11.82% | -31.47% | +19.74% | +24.15% | -35.82% | +4.40% | +10.81% | -17.42% | +36.27% | -23.15% | -33.11% | +13.46% | +23.04% | +41.64% | -46.21% | +28.21% | -14.51% | -57.21% | +48.77% | -17.03% | -8.67% | n/a | -100.00% | +55.13% | n/a |
| D U E X I S Product Revenue | n/a | 139K | 1.69M | 2.02M | 70K | 1.12M | 11.53M | 20.91M | 22.11M | 19.46M | 38.29M | 27.9M | 27.8M | 31.35M | 26.34M | 29.89M | 30.07M | 29.46M | 34.07M | 34.2M | 30.73M | 15.68M | n/a | 118.6M | 76.4M |
| D U E X I S Product Revenue Growth | -100.00% | -91.78% | -16.16% | +2781.43% | -93.77% | -90.26% | -44.86% | -5.40% | +13.59% | -49.16% | +37.23% | +0.36% | -11.32% | +19.01% | -11.88% | -0.59% | +2.07% | -13.54% | -0.37% | +11.29% | +96.01% | n/a | -100.00% | +55.24% | n/a |
| K R Y S T E X X A Revenue | 244.3M | 186.98M | 216.1M | 191.61M | 167.75M | 140.7M | 170.28M | 158.1M | 130.32M | 106.76M | 128.93M | 108.47M | 75.2M | 93.25M | 110.75M | 99.58M | 79.8M | 52.26M | 83.35M | 70.25M | 58.61M | 46.72M | n/a | n/a | n/a |
| K R Y S T E X X A Revenue Growth | +30.65% | -13.47% | +12.78% | +14.22% | +19.23% | -17.37% | +7.71% | +21.32% | +22.07% | -17.20% | +18.86% | +44.24% | -19.35% | -15.80% | +11.22% | +24.78% | +52.71% | -37.30% | +18.65% | +19.86% | +25.45% | n/a | n/a | n/a | n/a |
| P E N N S A I D Two Percent Revenue | 6.91M | 9.19M | 7.21M | 7.61M | 23.59M | 35.37M | 48.9M | 47.96M | 48.94M | 45.82M | 51.09M | 50.31M | 35.05M | 41.56M | 57.01M | 42.09M | 51.47M | 50.19M | 64.31M | 51.49M | 47.61M | 26.8M | n/a | n/a | n/a |
| P E N N S A I D Two Percent Revenue Growth | -24.81% | +27.43% | -5.13% | -67.76% | -33.31% | -27.67% | +1.95% | -2.00% | +6.82% | -10.31% | +1.53% | +43.56% | -15.67% | -27.09% | +35.43% | -18.23% | +2.56% | -21.95% | +24.90% | +8.14% | +77.63% | n/a | n/a | n/a | n/a |
| P R O C Y S B I Revenue | 53.15M | 50.46M | 54.93M | 57.78M | 47.71M | 49.57M | 47.48M | 49.35M | 49.77M | 43.36M | 47.29M | 43.11M | 41.36M | 38.34M | 40.8M | 40.4M | 41.17M | 39.57M | 40.16M | 41.37M | 38.43M | 34.93M | n/a | n/a | n/a |
| P R O C Y S B I Revenue Growth | +5.31% | -8.13% | -4.94% | +21.13% | -3.76% | +4.40% | -3.78% | -0.86% | +14.79% | -8.30% | +9.69% | +4.24% | +7.86% | -6.02% | +1.00% | -1.89% | +4.05% | -1.45% | -2.95% | +7.65% | +10.02% | n/a | n/a | n/a | n/a |
| Q U I N S A I R Revenue | 345K | 296K | 229K | 222K | 335K | 296K | 295K | 302K | 222K | 209K | 199K | 163K | 59K | 277K | 267K | 211K | 170K | 168K | 158K | 127K | 97K | 122K | n/a | n/a | n/a |
| Q U I N S A I R Revenue Growth | +16.55% | +29.26% | +3.15% | -33.73% | +13.18% | +0.34% | -2.32% | +36.04% | +6.22% | +5.03% | +22.09% | +176.27% | -78.70% | +3.75% | +26.54% | +24.12% | +1.19% | +6.33% | +24.41% | +30.93% | -20.49% | n/a | n/a | n/a | n/a |
| R A V I C T I Revenue | 88.35M | 90.32M | 87.47M | 84.2M | 75.72M | 78.26M | 74.38M | 76.32M | 68.43M | 72.82M | 70.23M | 64.65M | 65.55M | 61.19M | 68.46M | 59.95M | 50.44M | 49.9M | 60.16M | 60.44M | 56.96M | 49.09M | n/a | n/a | n/a |
| R A V I C T I Revenue Growth | -2.18% | +3.26% | +3.88% | +11.20% | -3.24% | +5.21% | -2.55% | +11.54% | -6.03% | +3.69% | +8.63% | -1.38% | +7.13% | -10.62% | +14.18% | +18.86% | +1.08% | -17.04% | -0.48% | +6.12% | +16.02% | n/a | n/a | n/a | n/a |
| R A Y O S Revenue | 8.01M | 4.98M | 6.68M | 10.57M | 11.15M | 13.49M | 13.3M | 14.87M | 13.41M | 15.27M | 21.01M | 18.13M | 14.46M | 18.21M | 19.53M | 19.36M | 20.28M | 19.42M | 18.77M | 18.64M | 21.86M | 8.38M | n/a | n/a | n/a |
| R A Y O S Revenue Growth | +60.98% | -25.48% | -36.79% | -5.24% | -17.33% | +1.41% | -10.58% | +10.94% | -12.22% | -27.31% | +15.88% | +25.40% | -20.59% | -6.75% | +0.87% | -4.56% | +4.43% | +3.47% | +0.72% | -14.72% | +160.84% | n/a | n/a | n/a | n/a |
| T E P E Z Z A Revenue | 445.53M | 405.32M | 493.51M | 490.94M | 479.81M | 501.45M | 589.62M | 616.36M | 453.25M | 2.06M | 343.75M | 286.87M | 165.94M | 23.45M | 10.36M | 13.09M | 14.62M | 14.04M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| T E P E Z Z A Revenue Growth | +9.92% | -17.87% | +0.52% | +2.32% | -4.31% | -14.95% | -4.34% | +35.99% | +21849.39% | -99.40% | +19.83% | +72.88% | +607.56% | +126.48% | -20.91% | -10.43% | +4.08% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| U P L I Z N A Revenue | 1.6M | 3.9M | 41.77M | 478K | 299K | 1.6M | 25.78M | 18.68M | 14.47M | 1.87M | 6.69M | 5.28M | 6.23M | 19.43M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| U P L I Z N A Revenue Growth | -58.97% | -90.66% | +8637.87% | +59.87% | -81.31% | -93.79% | +38.03% | +29.03% | +672.82% | -72.00% | +26.75% | -15.23% | -67.95% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Vimovo Revenue | n/a | 8K | 159K | n/a | n/a | 915K | 266K | 2.2M | 1.58M | 4.34M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Vimovo Revenue Growth | -100.00% | -94.97% | n/a | n/a | n/a | +243.98% | -87.93% | +39.32% | -63.59% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Non Us Revenue | 22.13M | 11.13M | 934.83M | 12.34M | 13.04M | 6.96M | 6.95M | 5M | 2.36M | 2.08M | 1.91M | 3.57M | 1.95M | 1.89M | 2.75M | 2.46M | 1.24M | 1.16M | 6.29M | 3.36M | 6.9M | 4.51M |
| Non Us Revenue Growth | +98.83% | -98.81% | +7478.02% | -5.40% | +87.49% | +0.07% | +38.97% | +111.64% | +13.82% | +8.86% | -46.52% | +82.68% | +3.12% | -31.14% | +11.98% | +97.51% | +6.97% | -81.51% | +87.05% | -51.28% | +52.90% | n/a |
| United States Revenue | 922.83M | 820.93M | n/a | 913.02M | 863.37M | 878.29M | 1.01B | n/a | 830.18M | 340.33M | 743.41M | 632.86M | 460.83M | 354.02M | 360.8M | 333.01M | 319.4M | 279.21M | 349.26M | 321.95M | 295.94M | 219.37M |
| United States Revenue Growth | +12.41% | n/a | n/a | +5.75% | -1.70% | -12.83% | n/a | n/a | +143.94% | -54.22% | +17.47% | +37.33% | +30.17% | -1.88% | +8.34% | +4.26% | +14.40% | -20.06% | +8.48% | +8.79% | +34.90% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 434.13M | 453.35M | 372.53M | 397.56M | 398.22M | 372.73M | 398.95M | 360.26M | 355.2M | 331.99M | 276.96M | 226.16M | 222.33M | 247.78M | 185.39M | 172.33M | 167.09M | 172.3M | 174.63M | 161.59M | 176.67M | 179.6M | 167.42M | 153.95M | 181.92M | 174.06M | 200.75M | 132.05M | 133.57M | 141.94M | 125.23M | 106.49M | 135.25M | 73.34M |
| Selling, General, and Administrative Revenue Growth | -4.24% | +21.69% | -6.30% | -0.17% | +6.84% | -6.57% | +10.74% | +1.42% | +6.99% | +19.87% | +22.46% | +1.72% | -10.27% | +33.65% | +7.58% | +3.13% | -3.02% | -1.33% | +8.07% | -8.54% | -1.63% | +7.27% | +8.75% | -15.38% | +4.51% | -13.29% | +52.02% | -1.14% | -5.89% | +13.35% | +17.60% | -21.26% | +84.40% | n/a |
| Research and Development Revenue | 150.03M | 134.15M | 117.53M | 114.06M | 103.25M | 103.13M | 140.91M | 93.55M | 139.83M | 57.69M | 70.88M | 30.21M | 81.07M | 27.21M | 28.56M | 24.57M | 28.31M | 21.73M | 19.68M | 21.17M | 24.27M | 17.64M | 30.87M | 17.93M | 163.1M | 13.06M | 23.96M | 12.81M | 11.21M | 12.72M | 13.69M | 13.07M | 8.92M | 6.18M |
| Research and Development Revenue Growth | +11.84% | +14.14% | +3.04% | +10.47% | +0.11% | -26.81% | +50.63% | -33.10% | +142.38% | -18.61% | +134.66% | -62.74% | +197.95% | -4.72% | +16.22% | -13.22% | +30.33% | +10.37% | -7.02% | -12.76% | +37.52% | -42.84% | +72.20% | -89.01% | +1148.76% | -45.49% | +86.99% | +14.31% | -11.88% | -7.06% | +4.71% | +46.53% | +44.35% | n/a |